CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway
Advanced Science · 2024
DOI: 10.1002/advs.202406611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Cheng Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. Hauptthemen laut MEDLINE: ErbB Receptors, Extracellular Matrix Proteins, Tendinopathy, MAP Kinase Signaling System. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Tendinopathy poses a formidable challenge due to the inherent limitations of tendon regenerative capabilities post‐injury. At present, effective curative approaches for tendinopathy are still lacking. Collagen triple helix repeat‐containing 1 (CTHRC1) is an extracellular matrix protein with significant roles in both physiological and pathological processes. The present study aims to investigate the function and underlying mechanism of CTHRC1 in tendinopathy. In this study, CTHRC1 is identified as a potential effector in promoting tendon regeneration through multi‐proteomic analysis of Achilles tendon tissues in mice. In vitro, CTHRC1 enhances the proliferation, migration, and tenogenic differentiation of tendon stem/progenitor cell (TSPC). In vivo, CTHRC1 deletion impairs tendon healing, while its overexpression reverses the detrimental effects caused by CTHRC1 deficiency. Mechanistically, proteomics on TSPC stimulated with recombinant CTHRC1 reveal that CTHRC1 activates the mitogen‐activated protein kinase (MAPK) signaling pathway via binding to epidermal growth factor receptor (EGFR), which in turn promotes the proliferative, migrative, and tenogenic capacities of TSPC to attenuate Achilles tendinopathy. Conversely, inhibiting EGFR reverses the tendon‐healing effect of CRHRC1. The study demonstrates that CTHRC1 can promote the proliferative, migrative, and tenogenic capacities of TSPC, ultimately facilitating tendon healing through activating the EGFR/MAPK signaling pathway. CTHRC1 holds promise as a potential intervention for tendinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
- Department of Bone and Joint Surgery, Department of Orthopedics, Renji Hospital, School of Medicine, Shanghai, 200001, China.
- Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
- Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, 361008, China.
- Shanghai Sixth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
- School of Medicine, Tongji University, Shanghai, 200092, China.
ORCID-Profile: Cheng Chen, TianBao Ye
Förderung
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Chen, C., Zheng, X., Wang, C., Zhou, H., Zhang, Y., Ye, T., & Yang, Y. (2024). CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway. Advanced Science. https://doi.org/10.1002/advs.202406611
Vancouver
Chen C, Zheng X, Wang C, Zhou H, Zhang Y, Ye T, et al. CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway. Advanced Science. 2024. doi:10.1002/advs.202406611
BibTeX
@article{Chen2024,
author = {Chen, Cheng and Zheng, Xu and Wang, Cheng and Zhou, HaiChao and Zhang, Yi and Ye, TianBao and Yang, YunFeng},
title = {CTHRC1 Attenuates Tendinopathy via Enhancing EGFR/MAPK Signaling Pathway},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202406611}
}
EUVIMED